Covid-19: Kenya joins Oxford University vaccine trial
Laboratory technicians handle capped vials of the University of Oxford’s Covid-19 vaccine candidate, AZD1222, at the Italian biologics’ manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, on September 11, 2020.
The trial in Kenya will initially involve 40 frontline workers in Kilifi County.
Once the vaccine safety is confirmed, a further 360 volunteers will be recruited with possible expansion of the trial to Mombasa County.
Kenya has joined global efforts to search for an effective vaccine for Covid-19 with the start of a trial evaluating vaccine candidate ChAdOx1 nCoV-19.
A trial team from the Kenya Medical Research Institute (Kemri) will carry out the experiment at the Kemri Wellcome Trust Research Programme in Kilifi County, a longstanding collaboration by Kemri, Oxford University and the Wellcome Trust in the UK
